Vimta Labs Limited
Vimta Labs' Board has recommended the re-appointment of Dr. S. P. Vasireddi as Executive Chairman for a five-year term, from July 1, 2026, to June 30, 2031. This re-appointment, subject to shareholder approval at the upcoming AGM, ensures continued leadership from the company's founder.
May 06 2026 18:05:00
Vimta Labs Limited
Vimta Labs Ltd recommended a final dividend of Rs.2 per equity share for the financial year 2025-26. The record date for the dividend is June 18, 2026, with the payment expected by July 08, 2026, following shareholder approval at the AGM on June 25, 2026.
May 06 2026 18:05:00
Vimta Labs Ltd-$ - 524394 - Announcement under Regulation 30 (LODR)-Change in Management
Vimta Labs' Board re-appointed Dr. S. P. Vasireddi as Executive Chairman for a five-year term. The re-appointment, effective from July 1, 2026, to June 30, 2031, is subject to shareholder approval at the upcoming Annual General Meeting.
May 06 2026 17:05:00
Vimta Labs Limited
Vimta Labs board recommended a Rs. 2 per equity share dividend for the financial year 2025-26. The record date is June 18, 2026, and payment will be made on or before July 08, 2026, subject to shareholder approval.
May 06 2026 17:05:00
Vimta Labs Limited
Vimta Labs board recommended a Rs. 2 per equity share dividend for the financial year 2025-26. The record date is June 18, 2026, and payment will be made on or before July 08, 2026, subject to shareholder approval.
May 06 2026 16:05:00
Vimta Labs Limited
Vimta Labs' Board has recommended the re-appointment of Dr. S. P. Vasireddi as Executive Chairman for a five-year term, from July 1, 2026, to June 30, 2031. This re-appointment, subject to shareholder approval at the upcoming AGM, ensures continued leadership from the company's founder.
May 06 2026 16:05:00
Vimta Labs Ltd-$ - 524394 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Vimta Labs reported strong FY26 financial results with revenue rising 19.5% YoY to Rs.416.3 crore and net profit increasing 16.1% YoY to Rs.77.5 crore. The growth was primarily fueled by robust performance in its Pharma and Food divisions, building on a strong Q4.
May 06 2026 16:05:00
Vimta Labs Ltd-$ - 524394 - Board Meeting Outcome for Q4 FY- 2025-26 - Audited Financial Results.
Vimta Labs approved FY26 results with revenue of ₹407.29 cr (up 18.4% YoY) and net profit of ₹77.51 cr (up 16.1% YoY). The board recommended a ₹2 dividend per share, approved a new wholly-owned US subsidiary, and reappointed Dr. S. P. Vasireddi as Executive Chairman for five years.
May 06 2026 15:05:00
Vimta Labs Ltd-$ - 524394 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Vimta Labs has scheduled an Analyst/Investor Conference Call on May 06, 2026, at 4:30 PM IST to discuss its Q4 FY26 financial results. The management will address the financial performance and future outlook.
Apr 29 2026 17:04:00
Vimta Labs Ltd-$ - 524394 - Board Meeting Intimation for Intimation Of Board Meeting Q4- Audited Financial Results- FY 2025-26
Vimta Labs' board of directors will convene on May 06, 2026. The agenda includes considering and approving the audited financial results for the fourth quarter and full financial year ended March 31, 2026, and recommending dividend payment.
Apr 29 2026 17:04:00
Read More